Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

483 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic myeloid leukemia outcomes according to baseline risk and first-line treatment in real-world settings: Data from the Italian Network/CML Campus.
Giai V, Rosso T, Castagnetti F, Pregno P, Bonifacio M, Capodanno I, Tiribelli M, Stagno F, Caocci G, Gozzini A, Luciano L, Galimberti S, Bocchia M, Patriarca A, Lanzarone G, Martino B, Guella A, Scortechini AR, Fava C, Fozza C, Sica S, Di Renzo N, Musto P, Pastore D, Maggi A, Pizzuti M, Antonia Melillo LM, Carella AM, Tarantini G, Mele A, Calistri E, Coppi MR, Saccona F, Scalzulli E, Battaglio B, Iezza M, Bitetti C, Freilone R, Rosti G, Albano F, Pane F, Specchia G, Ciccone G, Saglio G, Breccia M. Giai V, et al. Among authors: galimberti s. Cancer. 2025 Jul 1;131(13):e35963. doi: 10.1002/cncr.35963. Cancer. 2025. PMID: 40581844
Correction: Ventilation practices in acute brain injured patients and association with outcomes: the VENTIBRAIN multicenter observational study.
Robba C, Giardiello D, Almondo C, Asehnoune K, Badenes R, Cinotti R, Elhadi M, Graziano F, Helbok R, Jiang L, Chen W, Laffey JG, Messina A, Putensen C, Schultz MJ, Wahlster S, Rebora P, Galimberti S, Taccone FS, Citerio G; VENTIBRAIN study group. Robba C, et al. Among authors: galimberti s. Intensive Care Med. 2025 Jun 26. doi: 10.1007/s00134-025-07985-z. Online ahead of print. Intensive Care Med. 2025. PMID: 40571814 No abstract available.
Outcome of Chronic Myeloid Leukemia Patients Not in Deep Molecular Response: Results From the GIMEMA LabNet CML Network Database.
Stagno F, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, Sorà F, Soverini S, Messina M, Piciocchi A, Bonifacio M, Cilloni D, Iurlo A, Martinelli G, Rosti G, Fazi P, Vignetti M, Breccia M, Allegra A, Pane F. Stagno F, et al. Among authors: galimberti s. Am J Hematol. 2025 Jun 5. doi: 10.1002/ajh.27733. Online ahead of print. Am J Hematol. 2025. PMID: 40470709 No abstract available.
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Pisani I, Melita G, de Souza PB, Galimberti S, Savino AM, Sarno J, Landoni B, Crippa S, Gotti E, Cuofano C, Pedrini O, Capelli C, Matera G, Belotti D, Cesana S, Cabiati B, Quaroni M, Colombo V, Mazza M, Vergani B, Gaimari A, Nicolini F, Tazzari M, Bocchini M, Serafini M, Rambaldi A, Rambaldi B, Dastoli G, Biondi A, Gaipa G, Introna M, Golay J, Tettamanti S. Pisani I, et al. Among authors: galimberti s. J Transl Med. 2025 May 19;23(1):559. doi: 10.1186/s12967-025-06416-3. J Transl Med. 2025. PMID: 40390044 Free PMC article.
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.
Sicuranza A, Breccia M, Iuliano F, Gugliotta G, Castagnetti F, Lunghi M, Patriarca A, Intermesoli T, Luciano L, Russo Rossi A, Rege Cambrin G, Vucinic V, Malagola M, Malato A, Abruzzese E, D'Adda M, Galimberti S, Defina M, Sammartano V, Cafarelli C, Cencini E, Cartocci A, Pacelli P, Piciocchi A, Rughini A, Niederwieser D, Bocchia M. Sicuranza A, et al. Among authors: galimberti s. Vaccines (Basel). 2025 Apr 16;13(4):419. doi: 10.3390/vaccines13040419. Vaccines (Basel). 2025. PMID: 40333294 Free PMC article.
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
Mancini M, De Santis S, Monaldi C, Castagnetti F, Iezza M, Iurlo A, Cattaneo D, Galimberti S, Cerrano M, Capodanno I, Bonifacio M, Rossi M, Agostinelli C, Meggendorfer M, Haferlach T, Cavo M, Gugliotta G, Soverini S. Mancini M, et al. Among authors: galimberti s. Clin Transl Med. 2025 Apr;15(4):e70163. doi: 10.1002/ctm2.70163. Clin Transl Med. 2025. PMID: 40275711 Free PMC article.
Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study.
Castellino A, Comba L, Bertolotti L, Boccomini C, Clerico M, Nicoli P, Vanazzi A, Fanelli F, Perrone T, Marchesi F, Cocito F, Merli M, Bigliardi S, Mecacci B, Bozzoli V, Margiotta-Casaluci G, Meli E, Anastasia A, Farina L, Annibali O, Conconi A, Rattotti S, Galimberti S, Castellino C, Massaia M. Castellino A, et al. Among authors: galimberti s. Ann Hematol. 2025 Apr;104(4):2579-2580. doi: 10.1007/s00277-025-06369-z. Ann Hematol. 2025. PMID: 40259004 Free PMC article. No abstract available.
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Lussana F, Magnani CF, Galimberti S, Gritti G, Gaipa G, Belotti D, Cabiati B, Napolitano S, Ferrari S, Moretti A, Buracchi C, Borleri GM, Rambaldi B, Rizzuto G, Grassi A, Paganessi M, Meli C, Tettamanti S, Risca G, Pais G, Spinozzi G, Benedicenti F, Cazzaniga G, Capelli C, Gotti E, Introna M, Golay J, Montini E, Balduzzi A, Valsecchi MG, Dastoli G, Rambaldi A, Biondi A. Lussana F, et al. Among authors: galimberti s. Blood Cancer J. 2025 Apr 3;15(1):54. doi: 10.1038/s41408-025-01260-6. Blood Cancer J. 2025. PMID: 40180925 Free PMC article. Clinical Trial.
483 results